Optimal glycaemic targets for women with gestational diabetes: the randomised trial - TARGET

Not Applicable

Completed

• Conditions: Gestational Diabetes Mellitus; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12615000282583
• Lead Sponsor: niversity of Auckland, Research Office

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-03-25
• Study Completion: 2018-08-06
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1100

Inclusion Criteria

Hospital providing care for women with gestational diabetes diagnosed between 22 weeks' gestation and 34 weeks' gestation.

Exclusion Criteria

Women where the fetus has a major anomaly.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
arge for gestational age infant (defined as birth weight >90th centile using customised charts)[At birth]